Mizushima T, Ikeda M, Kato T, Ikeda A, et al. Postoperative XELOX therapy for patients with curatively resected high-risk stage
II and stage III rectal cancer without preoperative chemoradiation: a
prospective, multicenter, open-label, single-arm phase II study. BMC Cancer 2019;19:929.
PMID: 31533662